MAR
33
3
AAPL
52
4
TRV
59
7
NEM
50
2
DIS
69
15
GS
49
4
VRSN
53
4
VLO
45
3
DGX
57
3
EW
32
-2
IP
54
4
NI
73
3
CMS
68
3
SO
70
4
MKC
63
-2
BK
68
5
CMCSA
48
2
JCI
45
4
PGR
68
4
TEL
63
5
MAR
33
3
AAPL
52
4
TRV
59
7
NEM
50
2
DIS
69
15
GS
49
4
VRSN
53
4
VLO
45
3
DGX
57
3
EW
32
-2
IP
54
4
NI
73
3
CMS
68
3
SO
70
4
MKC
63
-2
BK
68
5
CMCSA
48
2
JCI
45
4
PGR
68
4
TEL
63
5
Financhill
Back

Integra Lifesciences Holdings Stock Predictions

Your Data Made Them Billions-Now It's Your Turn to Profit

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20

IART
Integra Lifesciences Holdings

Last Price:
$23.13
Seasonality Move:
2.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Economy going through a "period of transition" - Your portfolio doesn't have to

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Integra Lifesciences Holdings Stock Forecast

  • Over the next 52 weeks, Integra Lifesciences Holdings has on average historically risen by 16.2% based on the past 29 years of stock performance.
  • Integra Lifesciences Holdings has risen higher in 16 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.17%
  • Is Integra Lifesciences Holdings Stock Undervalued?
    The current Integra Lifesciences Holdings [IART] share price is $22.35. The Score for IART is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • IART is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Integra Lifesciences Holdings Stock Go Up Next Year?

  • Over the next 52 weeks, Integra Lifesciences Holdings has on average historically risen by 16.2% based on the past 29 years of stock performance.

Integra Lifesciences Holdings Stock Rating

Sell
20
Integra Lifesciences Holdings (IART) is a Sell

Is Integra Lifesciences Holdings overpriced?

  • Integra Lifesciences Holdings has risen higher in 16 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.17%

Integra Lifesciences Holdings Stock Price History

Is IART stock going to rise?

  • The current trend is relatively stagnant and IART is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
integralife.com

52-Week Data

52-Week High:
35.49
52-Week Low:
16.81

Prediction Charts

Market Cap:
1.8B
Price in USD:
22.35
Volume:
543.6K
Beta:
0.94

Technical Analysis

SMA50:
23.75
SMA100:
23.18
SMA200:
23.76
52-Wk Change:
-38.44%

Stock Predictions

  • Is Integra Lifesciences Holdings stock public?
    Yes, Integra Lifesciences Holdings is a publicly traded company.
  • What is the Integra Lifesciences Holdings stock quote today?
    The Integra Lifesciences Holdings stock price is 22.35 USD today.
  • How to buy Integra Lifesciences Holdings stock online?
    You can buy Integra Lifesciences Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-25 21.50 24.72 25.45 21.25
Feb-26 24.50 23.60 24.86 23.46
Feb-27 23.40 23.10 23.50 22.80
Feb-28 23.06 23.21 23.25 22.43
Mar-3 23.30 22.48 23.56 22.44
Mar-4 22.11 21.91 22.35 21.67
Mar-5 21.99 21.87 22.31 21.84
Mar-6 21.66 22.03 22.09 21.43
Mar-7 22.07 23.00 23.19 21.77
Mar-11 22.76 23.95 24.12 22.46
Mar-12 23.89 22.24 24.37 22.01
Mar-13 22.20 22.27 22.73 22.12
Mar-14 22.32 22.35 22.89 22.05
Mar-17 22.26 23.12 23.27 22.01

Integra Lifesciences Holdings Earnings

Integra Lifesciences Holdings Earnings Report: Per Share Integra Lifesciences Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.

Integra Lifesciences Holdings Forecast Revenue Growth

Integra Lifesciences Holdings Stock Analysis: Historical quarterly revenues per share for Integra Lifesciences Holdings and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.01 per share, and an increase next year of $0.25 per share.

* Integra Lifesciences Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.